Highly Enantioselective Hydrogenation of Ethyl 5,5‐Dimethoxy‐3‐oxopentanoate and its Application for the Synthesis of a Statin Precursor

Authors:

Abstract
The highly enantioselective hydrogenation of ethyl 5,5‐dimethoxy‐3‐oxopentanoate (3) to ethyl 3‐hydroxy‐5,5‐dimethoxypentanoate (4) – a key intermediate in the synthesis of pharmacologically important statin drugs – has been investigated. The stereochemistry of the catalytic hydrogenation of the β‐keto ester in the presence of a number of homogeneous chiral RhI and RuII complexes with phosphane ligands has been studied. The highest enantioselectivity for the homogeneous hydrogenation of 3 (up to 98.7 % ee) was achieved through an optimized version of Genêt's procedure with a Ru[(R)‐BINAP]Cl2 pre‐catalyst (substrate/catalyst ratio up to 20 000:1, 50 bar H2, 50 °C, in MeOH). The transformation of alcohol R‐(4) into ylide R‐(6) as an important precursor of the chiral side chain of rosuvastatin is also illustrated. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2008)

This publication has 33 references indexed in Scilit: